Monaco Asset Management Sam Teva Pharmaceutical Industries LTD Transaction History

Monaco Asset Management Sam

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$12.78 - $17.4 $11.4 Million - $15.5 Million	-889,121 Reduced 65.18%	475,000 $7.72 Million
Q1 2024 May 09, 2024	SELL	$10.67 - $14.43 $33,919 - $45,872	-3,179 Reduced 0.23%	1,364,121 $19.2 Million
Q4 2023 Feb 07, 2024	SELL	$8.12 - $10.63 $1.28 Million - $1.68 Million	-157,700 Reduced 10.34%	1,367,300 $14.3 Million
Q3 2023 Nov 07, 2023	BUY	$7.48 - $10.7 $4.42 Million - $6.32 Million	590,587 Added 63.2%	1,525,000 $15.6 Million
Q2 2023 Aug 08, 2023	BUY	$7.2 - $9.47 $6.73 Million - $8.85 Million	934,413 New	934,413 $7.04 Million
Q4 2022 Jan 31, 2023	SELL	$7.95 - $9.48 $469,050 - $559,320	-59,000 Reduced 44.03%	75,000 $684,000
Q3 2022 Oct 31, 2022	BUY	$6.86 - $11.95 $919,240 - $1.6 Million	134,000 New	134,000 $1.08 Million

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.5B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Monaco Asset Management Sam, based on Form 13F filings with the SEC.

Stay updated on Monaco Asset Management Sam with notifications on news.